Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cost Effectiveness of Sirolimus Eluting Stents vs. Vasculary Brachytherapy for In-Stent Restenosis: Results from the SISR Trial

Cost Effectiveness of Sirolimus Eluting Stents vs. Vasculary Brachytherapy for In-Stent Restenosis: Results from the SISR Trial. American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. 2007.


© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.